baber/WOPTO huggingface dataset:
Patent DE-69811417-T2 (DE)
Inventor: COUVREUR MICHEL
IPC: F24B1/195
Filed: 1998-03-17
Granted: 2003-12-04
Abstract: The combustion regulator is for a fireplace with a double hearth which can be closed. It is connected to an outlet duct (10) and is enclosed by a series of refractory panels (14,15). Its upper wall is made in two separate sections (4,5) which can be moved relative to one another on guides. The sections can be easily adjusted to regulate the size of an additional air intake gap between them. The rear panel of the fireplace has an aperture (16) to allow the direct passage of combustion gases into the outlet duct in proportion to the intake of air between the separable sections of the upper wall. The upper wall sections are made in the form of sliding panels and the guides are in the form of ledges round a central aperture.
Patent DE-69813783-T2 (DE)
Inventor: SRINIVASAN K G
IPC: C08L67/02
Filed: 1998-09-11
Granted: 2004-06-09
Abstract: A solid coating composition for use in powder coating and extrusion coating applications is disclosed. The coating composition contains about 70 to about 95% of a base resin, such as a polyester, and about 1 to about 50% of a low-to-medium molecular weight end-capped epoxy resin, and is essentially free of a bisphenol-A diglycidyl ether monomer. The solid coating composition is applied to a metal substrate in a powder coating or an extrusion process to provide a metal article having a composition film having a thickness of about 1 to about 200 microns. The metal articles can be used to package food and beverages.
Patent DE-69814134-T2 (DE)
Inventor: DE JONG JOHANNES
IPC: B66B7/04
Filed: 1998-11-05
Granted: 2003-11-20
Abstract: Elevator guide shoe for guiding an elevator car along guide rails in an elevator shaft, said guide shoe comprising a supporting frame (2) attached to the elevator car (1) and guides (4) resting against a guide rail (3). According to the invention, the guide shoe comprises an intermediate frame (5), to which the guides (4) are attached. In addition, the supporting frame (2) and the intermediate frame (5) are provided with permanent magnet bars (6a, 6b, 7a, 7b, 8a, 8b) arranged to maintain a horizontal distance between the supporting frame and the intermediate frame. Moreover, the guide shoe comprises vertical suspension (9) between the supporting frame and the intermediate frame to damp the propagation of sound in the structures.
Patent DE-69814584-T2 (DE)
Inventor: JORET LAURENT
IPC: B60J7/00
Filed: 1998-07-29
Granted: 2004-04-08
Abstract: The invention concerns a transparent glass substrate provided with at least a hot-deposited thin coating based on metal nitride reflecting at least partially solar radiation in wavelengths of the visible and/or infrared domain. The invention is characterised in that the metal nitride comprises zirconium nitride ZrN at least partly crystallised.
Patent DE-69821600-T2 (DE)
Inventor: KOHN B
IPC: A61L31/14
Filed: 1998-02-18
Granted: 2005-01-05
Abstract: A dihydroxy compound characterized by the formula:Wherein R1 and R2 are independently selected from hydrogen and straight and branched alkyl groups containing up to 18 carbon atoms; R3 is selected from -CH=CH- and (-CH2-)k, wherein k is between 0 and 6, inclusive; each Z is independently bromine or iodine, d and n are independently 0, 1 or 2; and X is hydrogen or a pendant group having the structure:wherein Y is selected from straight and branched alkyl and alkyl and alkylaryl groups containing up to 18 carbon atoms.
Patent DE-69824868-T2 (DE)
Inventor: ANTILA JUHANI
IPC: A23L29/231
Filed: 1998-08-26
Granted: 2005-07-28
Abstract: The invention relates to a method of preparing crystalline L-arabinose by extraction of sugar beet pulp, from which sugar has been extracted, in a strong alkaline solution, by hydrolysis of the obtained crude araban with a strong acid at an elevated temperature, by neutralization and filtration of the obtained solution, by chromatographic separation of the L-arabinose fraction, by purification of the obtained L-arabinose solution by means of cation and anion exchangers and adsorbent resins, and by recovering the pure L-arabinose as a crystalline product.
Patent DE-69833554-T2 (DE)
Inventor: PFIRRMANN ROLF
IPC: A61K31/549
Filed: 1998-07-31
Granted: 2006-08-10
Abstract: The invention provides the use of taurolidine or taurultam solutions to prevent or reduce metastatic growth. This is of particular application in preventing or reducing the incidence of metastatic growth following surgery, particularly following the use of trocars during minimal invasive laparoscopic surgery.
Patent DE-69839357-T2 (DE)
Inventor: MCMICHAEL ANDREW JAMES
IPC: A61P31/18
Filed: 1998-06-09
Granted: 2009-07-02
Abstract: New methods and reagents for vaccination are described which generate a CD8 T cell immune response against malarial and other antigens such as viral and tumour antigens. Novel vaccination regimes are described which employ a priming composition and a boosting composition, the boosting composition comprising a non-replicating or replication-impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition.
Patent DE-69905925-T2 (DE)
Inventor: BORDIGNON GIUSEPPE
IPC: B21C47/34
Filed: 1999-11-01
Granted: 2003-11-13
Abstract: Coiling line located downstream of a rolling train provided with shears suitable to shear the rolled stock emerging from the rolling train, comprising a first coiling machine suitable to coil the rolled stock to achieve a corresponding first coil, downstream of the shears there being included at least a second coiling machine suitable to coil the rolled stock to achieve a corresponding second coil, selection means being provided to take the rolled stock to wind alternatively either onto the first or onto the at least second coiling machine.
Patent DE-69911068-T2 (DE)
Inventor: MILLER G
IPC: C03C25/10
Filed: 1999-12-13
Granted: 2004-07-15
Abstract: A nonaqueous sizing for glass fibers useful for reinforcement of polymers. The sizing composition comprises one or more film formers miscible with the polymer to be reinforced, one or more coupling agents and one or more powders. The sizing composition of the invention provides a glass fiber which has improved processability and notched izod without any loss in dispersability characteristics of the glass pellets.
Patent DE-69915857-T2 (DE)
Inventor: WESTON MARTIN
IPC: H04N7/01
Filed: 1999-11-03
Granted: 2005-02-10
Abstract: Motion between adjacent fields of an interlaced video signal is analyzed by vertically interpolating the current field to produce a line signal which corresponds in vertical position with lines from the succeeding and preceding fields; and subtracting the signals to provide a field difference. The effect of vertical detail is reduced by comparing two field differences or by subtracting a local or global detail signal from the field difference.
Patent DE-69925921-T2 (DE)
Inventor: COLE HAROLD
IPC: G06K19/08
Filed: 1999-07-20
Granted: 2006-05-11
Abstract: A metal screened ( 13 ) electronic labelling system having at least one information bearing electronic coded label including a label coil ( 12 ) and an interrogator including a transmitter coil ( 9 ). The system relies on a magnetic field coupling link containing the transmitter coil ( 9 ) and the label coil ( 12 ) for obtaining information from the label. The coupling link is arranged such that it operates in the near field thereof and substantially none or at most a minority of the magnetic flux which excites the label coil ( 12 ) also links the transmitter coil ( 9 ).
Patent DE-69930456-T2 (DE)
Inventor: LOVEL NIGEL
IPC: F21V8/00
Filed: 1999-11-09
Granted: 2006-12-07
Abstract: A lighting unit is disclosed comprising a casing (10) having two separable portions (12,14) which are slidably engagable with one another. In a first portion (14) of the casing (10) is disposed a light source, an electrical fan and one part of a plug and socket electrical connection. The second portion (12) of the casing (10) carries an optical light transmitting cable (40) having one end connected to said portion which receives light from the light source and transmit it to the other end of the cable (40) remote from the casing (10), and further comprises the alternate component of the electrical connection. The second portion (12) of the casing (10) also comprises a power supply means by which electrical power is supplied through the electrical connection (30) to the components provided in the second portion of the casing (10). The invention is advantageous in that sliding engagement of the respective casing portions automatically makes an electrical connection while simultaneously bringing the light source into correct disposition and register with the end of the optical cable (40) mounted in the alternate portion to that in which the light source is disposed. The second portion (12) is also ideally provided with a duct (42) through which air is expelled or from which air is drawn by the fan, said air passing over the light source to cool same. <IMAGE>
Patent DE-69936049-T2 (DE)
Inventor: MURPHY GERALD P
IPC: G01N33/68
Filed: 1999-03-18
Granted: 2008-01-10
Abstract: The present invention relates to monoclonal antibodies that bind to the extracellular domain of prostate-specific membrane antigen (PSMA), hybridoma cell lines producing the antibodies, and methods of using such antibodies for diagnosis and treatment of cancer. In particular, thirty-five monoclonal antibodies reactive with PSMA expressed on the cell surface are exemplified. Additionally, the present invention relates to a novel protein variant (PSM') of PSMA detected by a number of the antibodies of the invention. The hydrolase activity of PSMA and PSM' allows the use of an immunoenzymatic assay for their detection.
Patent DE-69937570-T2 (DE)
Inventor: PRESNELL SCOTT R
IPC: C07K16/42
Filed: 1999-09-17
Granted: 2009-04-23
Abstract: An isolated polynucleotide which encodes a polypeptide, wherein said polypeptide comprises an amino acid sequence that is at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:9, SEQ ID NO:12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO:15, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21 and SEQ ID NO:22; the encoded polypeptide; and antibody that binds specifically thereto; and therapeutic uses thereof.
Patent HU-E025408-T2 (HU)
Title: Use of igfbp-7 in the assessment of heart failure
Inventor: WIENHUES-THELEN URSULA-HENRIKE
IPC: G01N33/68
Filed: 2008-01-25
Abstract: The invention relates to a method for assessing heart failure in vitro comprising the steps of measuring in a sample the concentration of the marker IGFBP-7, of optionally measuring in the sample the concentration of one or more other marker(s) of heart failure, and of assessing heart failure by comparing the concentration determined in for IGFBP-7 and the concentration(s) determined for the optionally one or more other marker to the concentration of this marker or these markers as established in a reference population. Also disclosed are the use of IGFBP-7 as a marker protein in the assessment of heart failure, a marker combination comprising IGFBP-7 and a kit for measuring IGFBP-7.
Patent HU-E033099-T2 (HU)
Title: Novel tricyclic compounds
Inventor: WISHART NEIL
IPC: A61P19/00
Filed: 2010-12-01
Abstract: The invention provides compounds of Formula (I) and Formula (II)
   
pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Patent HU-E029027-T2 (HU)
Title: Methods of treating multiple myeloma using combination therapies based on HuLuc63 with bortezomib
Inventor: AFAR DANIEL
IPC: A61P35/00
Filed: 2007-08-07
Abstract: Composition suitable for treating multiple myeloma in subject, comprising a therapeutically effective amount of HuLuc63, a therapeutically effective amount of lenalidomide and/or bortezomib, and a pharmaceutically acceptable carrier, wherein said composition is capable of being administered in a single or multiple dose regimen.
Patent MD-3409259-T2 (MD)
Inventor: DI NARO ANTONIO FRANCESCO
IPC: F26B5/06
Filed: 2017-07-12
Abstract: Metodă de preparare a unui produs farmaceutic într-un singur sac flexibil cu o multitudine de camere.Un produs farmaceutic este introdus în stare lichidă într-o primă cameră a sacului flexibil printr-un prim port. Produsul farmaceutic este liofilizat în prima cameră a sacului flexibil pentru a obţine un produs farmaceutic liofilizat. Sacul flexibil are o a doua cameră şi prima cameră şi cea de-a doua cameră sunt separate de un sigiliu care se poate rupe. Cea de-a doua cameră include suplimentar o soluţie de receonstituire pentru reconstituirea produsului farmaceutic liofilizat în prima cameră. Un utilizator poate aplica presiune asupra sacului flexibil pentru a rupe sigiliul şi a amesteca produsul farmaceutic liofilizat şi soluţia de reconstituire pentru a administra produsul farmaceutic la un pacient.
Patent TR-200000756-T2 (TR)
Title: Davranış bozukluğu tedavisi.
Inventor: HEILIGENSTEIN JOHN HARRISON
IPC: A61K31/5375
Filed: 1998-09-01
Abstract: Norepinefrini geri alma inhibitörleri davranis bozuklugunun tedavisinde kullanilmaktadirlar.
Patent TR-200000920-T2 (TR)
Title: Pektin metilesterazı ve ilave edilmiş hidrokolloidi olan meyve-yada sebze-temelli bir ürünün hazırlanmasına mahsus yöntem
Inventor: GIDLEY MICHAEL JOHN
IPC: A23L29/231
Filed: 1998-09-10
Abstract: Bir meyve-yada sebze-temelli ürünün hazirlanmasina mahsus yöntem olup, ki içinde,pektin metilesteraz ve istege bagli olara pektin, bir meyve-yada sebze hamuruna ilave edilmektedir. sözü edilen karisim dinlenmeye birakilmaktadir, istege bagli olara bunu takiben sözü edilen karisim tesirsiz hale getirilmektedir. Sözü edilen karisim bir hidrokolloit ilave edilmektedir.
Patent TR-200001844-T2 (TR)
Inventor: GERRAND ALAN ROY
IPC: A43B23/00
Filed: 1998-11-23
Abstract: Improvements in footwear for sporting purposes requiring the kicking of a ball on or adjacent to an instep of the footwear, there being provided at least one insert (24) for or in addition to the footwear which is attachable to the footwear on or adjacent to the instep such that a concave kicking surface (28) is provided, the radius of curvature of the kicking surface (28) being substantially the same as or slightly greater than the radius of the ball, the at least one insert (24) being of a maximum height at the front of the instep at least as great as the maximum height at the rear of the instep.
Patent TR-200002661-T2 (TR)
Title: İçeriyi yansıtmayan bronz cam
Inventor: KRUMWIEDE JOHN F
IPC: C03C4/02
Filed: 1999-03-15
Abstract: Mevcut bulus yüzde 60'a dek bir isik transmitansina sahip bronz renklendirilmis, kizilötesi ve morötesi sogurumlu bir cam bilesimi sunmaktadir. Cam standart bir soda-kireç-silisli cam bazi bilesimi ve ilaveten, kizilötesi ve morötesi isinim sogurma malzemesi ve renklendirici olarak demir ve selenyum ve istege bagli olarak kobalt kullanmaktadir. Mevcut bulusa mahsus cam yüzde 60'a dek bir isik transmitansina (LTA) sahiptir ve renginin özelligi 0.160 inç bir kalinlikta (4.06 milimetre ) 560 ila 590 nanometre dagiliminda bir hakim dalga boyu ve yüzde 12 ila 75 bir uyarim safligi ile belirlenmektedir.
Patent TR-200100062-T2 (TR)
Inventor: GASPARO MARC DE
IPC: A61K31/137
Filed: 1999-07-09
Abstract: The invention relates to a method for the treatment or prevention of a condition or disease selected from the group consisting of hypertension, (acute and chronic) congestive heart failure, left ventricular dysfunction and hypertrophic cardiomyopathy, myocardial infarction and its sequelae, supraventricular and ventricular arrhythmias, atrial fibrillation or atrial flutter, atherosclerosis, angina (whether stable or unstable), renal insufficiency (diabetic and non-diabetic), heart failure, angina pectoris, diabetes, hypertension in patients with NIDDM, secondary aldosteronism, primary and secondary pulmonary hyperaldosteronism, primary and pulmonary hypertension, renal failure conditions, such as diabetic nephropathy, glomerulonephritis, scleroderma, glomerular sclerosis, proteinuria of primary renal disease, and also renal vascular hypertension, diabetic retinopathy, the management of other vascular disorders, such as migraine, Raynaud's disease, luminal hyperplasia, cognitive dysfunction (such as Alzheimer's), and stroke, comprising administering a therapeutically effective amount of combination of (i) the AT 1 -antagonists valsartan or a pharmaceutically acceptable salt thereof and (ii) a Calcium channel blocker or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier to a mammal in need of such treatment and to corresponding pharmaceutical combination composition.
Patent DE-602004005028-T2 (DE)
Inventor: MENSCH PATRICK PAUL YVONNE
IPC: H04L12/18
Filed: 2004-08-06
Granted: 2007-11-15
Abstract: The present invention relates to a relay unit (21) for use in a data communication system (1) operable to transmit multicast traffic, and adapted to receive a membership report (61) from a particular station (11), whereby a membership of a particular multicast group is notified.  A relay unit according to the invention is characterized in that the relay unit is further adapted:  to query (71, 72) a plurality of multicast routers (41 to 44) over a plurality of virtual broadcast domains (51, 52) as to whether that particular multicast group is supported,  to elect one virtual broadcast domain (51) out of the plurality of virtual broadcast domains, over which one multicast router (41) out of the plurality of multicast routers has notified (81) support of that particular multicast group,  to report the membership to that multicast router over that virtual broadcast domain,  to transmit a particular multicast content (91), related to that particular multicast group and originating from that multicast router, from that virtual broadcast domain towards that particular station.    The present invention also relates to a method for relaying multicast traffic within a data communication system.
Patent DE-602004005892-T2 (DE)
Inventor: DIAZ PHILIPPE
IPC: C07D249/12
Filed: 2004-12-08
Granted: 2007-12-20
Abstract: Novel compounds that are modulators of PPAR-type receptors having the structural formula (I): are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and in the field of cardiovascular diseases, immune diseases and/or diseases linked to the metabolism of lipids), or, alternatively, into cosmetic compositions.
Patent DE-602004006223-T2 (DE)
Inventor: XU WEI
IPC: C08F10/00
Filed: 2004-03-12
Granted: 2008-01-17
Abstract: The present invention relates to a catalyst composition for polymerization of olefins comprising at least two catalytic components; and the polymerization process using that catalyst composition. The catalyst composition comprises:  a) at least two catalytic components, wherein a first catalytic component (A) is of the formula (I) <CHEM> wherein: M1 is a transition metal from the lanthanides or from group 3, 4, 5 or 6 of the Periodic System of Elements, Q1 is an anionic ligand to M1, k is the number of Q1 groups and is equal to the valence of M1 minus 2, R1 is a bridging group and Z<1>-Z<6> and X<1>-X<4> are substituents, wherein R1 contains at least one sp2-hybridized carbon atom that is bonded to the indenyl group at the 2-position, and wherein a second catalytic component (B) is also active for catalyzing the polymerization of olefins and is different from the catalytic component (A);and b) a cocatalyst.
Patent DE-602004009776-T2 (DE)
Inventor: KOWALESKI RUTH MARY
IPC: C07C213/04
Filed: 2004-03-30
Granted: 2008-08-28
Abstract: A process for the epoxidation of an olefin, which process comprises reacting a feed comprising an olefin, oxygen and an organic halide, in the presence of a catalyst comprising silver and rhenium deposited on a carrier, wherein the catalyst comprises rhenium in a quantity of at most 1.5 mmole/kg, relative to the weight of the catalyst, and at most 0.0015 mmole/m2, relative to the surface area of the carrier, and in which process the reaction temperature is increased to at least partly reduce the effect of loss of activity of the catalyst while the organic halide is present in a relative quantity Q which is maintained constant as defined herein.
Patent DE-602005000787-T2 (DE)
Inventor: THIEBAUT LAURE
IPC: B65D83/00
Filed: 2005-02-04
Granted: 2008-01-10
Abstract: The device has a wall (3) rotatable relatively to another wall around a rotational axis (7). The wall (3) has a peripheral edge (51) having a portion that is in watertight engagement with an inner surface of a housing, when the wall (3) is rotated around the axis. The wall delimits an outlet orifice (14) for permitting distribution of a cosmetic product in response to a decrease of an angular gap defined between the walls. An independent claim is also included for an assembly including two product distributing devices.
Patent DE-602005001890-T2 (DE)
Inventor: CONLON SEAN P
IPC: A61F2/958
Filed: 2005-06-15
Granted: 2008-04-30
Abstract: A method of assembling a surgically implantable fluid adjustable device (1). The device has an elongated substantially air impermeable flexible inflatable portion (10), an elongated flexible and substantially inextensible band portion (20) attached to the inflatable portion, and a catheter tube (50) in fluid communication with the inflatable portion. The catheter tube has a distal end (52) attached to the inflatable portion and an open proximal end (54) extending therefrom. The method involves substantially evacuating the inflatable portion of fluids, and inserting a removable plug (70) into the open proximal end of the catheter tube such that it substantially prevents introduction of air through the proximal end. <IMAGE>
Patent DE-602005003824-T2 (DE)
Inventor: COOKE MICHAEL P
IPC: F02M51/06
Filed: 2005-08-24
Granted: 2008-12-04
Abstract: An injection nozzle for an internal combustion engine includes a nozzle body (10) provided with a bore (14) within which a valve needle (16) is movable along a primary valve needle axis (A-A), the valve needle (16) being engageable with a valve seating (18) defined by the bore (14) to control fuel delivery through an injection nozzle outlet (20). The nozzle includes a first valve region (28; 128; 228), a second valve region (30; 230; 330; 44) and a seating region (38; 138; 238) located between the first and second valve regions which seats against the valve seating (18) when the nozzle is in a non-injecting state. A diffusion volume (36) is defined between the valve needle (16) and the bore (14) downstream of the valve seating (18) and into which fuel flows once it has flowed past the valve seating (18) when the valve needle (16) is lifted from the valve seating (18) into an injecting state. The valve needle (16) is provided with a diffusion region (38; 138; 40; 140) of part-spheroidal or part-spherical form to define a smooth transition for a diverging fuel flow into the diffusion volume (36), thereby to minimise turbulence within the diffusion volume (36).
Patent DE-3587875-T3 (DE)
Inventor: BANDYOPADHYAY PRADIP
IPC: C12N15/81
Filed: 1985-12-04
Granted: 2003-01-02
Abstract: A synthetic DNA sequence and its genetic equivalents which sequencies are capable, when used in a recombinant DNA method, of directing production of a serine protease inhibitor protein. Recombinant DNA methods for the production of serine protease inhibitor proteins are also disclosed. These methods incorporate either the synthetic DNA sequence of the present invention or natural DNA sequences isolated from human cDNA or genomic libraries.